open/close global search bar

24 January 2013 by Serge Adnot

Lecture

Pulmonary Hypertension: A Cancerous Proliferative Vascular Disorder?

All credit to Prof. Serge Adnot, Professor of Physiology at INSERM, Creteil, France

Part 3

 

Additional key-words:  malignancy,clinical trials,serotonin

About the author

profile picture of Serge Adnot

Serge Adnot

Pr

Henri Mondor Hospital

France

Related Content

Imatinib in pulmonary arterial hypertension: c-Kit inhibition thumbnail image

Original Research

{{GlobalController.truncateTitle("Imatinib in pulmonary arterial hypertension: c-Kit inhibition", 65)}}
Possible role of lysophosphatidic acid in rat model of hypoxic pulmonary vascular remodeling thumbnail image

Original Research

{{GlobalController.truncateTitle("Possible role of lysophosphatidic acid in rat model of hypoxic pulmonary vascular remodeling", 65)}}
PHD3 controls an EMT phenotype and therapeutic resistance in lung cancer through TGFa thumbnail image

Abstract

27 January 2014

{{GlobalController.truncateTitle("PHD3 controls an EMT phenotype and therapeutic resistance in lung cancer through TGFa", 65)}}
Androgen receptor interaction with WNT/_-Catenin pathway as a novel signalling hub at the blood-brain barrier (and the implications of vascular ageing) thumbnail image

Abstract

27 January 2014

{{GlobalController.truncateTitle("Androgen receptor interaction with WNT/_-Catenin pathway as a novel signalling hub at the blood-brain barrier (and the implications of vascular ageing)", 65)}}
Methylation of SOD2 in FHR PASMC is reversible by 5-AZA thumbnail image

Atlas image

01 January 2015

{{GlobalController.truncateTitle("Methylation of SOD2 in FHR PASMC is reversible by 5-AZA", 65)}}

Add to reading list

Please enter a list name.

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI
standard-example-image.jpg